BP
IRMD icon

Ballentine Partners’s iRadimed IRMD Stock Holding History

Ballentine Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Hold
2,172
– – ﹤0.01% 994
2026
Q1 		$209K Hold
2,172
– – ﹤0.01% 922
2025
Q4 		$211K Buy
+2,172
New +$186K ﹤0.01% 901

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ballentine Partners's IRMD Position: Q2 2026 in Review

Ballentine Partners held its iRadimed (IRMD) position steady in Q2 2026 at 2,172 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #994.

Ballentine Partners first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $211K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Ballentine Partners held 2,172 shares of iRadimed worth $208K as of Q2 2026.
  • Ballentine Partners left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #994 holding.
  • Ballentine Partners first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Ballentine Partners's iRadimed position peaked at $211K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.